Breakdown | ||||
Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
121.00B | 112.36B | 301.02B | 318.98B | 277.07B | Gross Profit |
121.00B | 136.07B | 301.02B | 318.98B | 277.07B | EBIT |
121.00B | 19.91B | 1.88B | 4.89B | 7.73B | EBITDA |
23.73B | 19.85B | 13.31B | 16.45B | 20.59B | Net Income Common Stockholders |
8.43B | 5.37B | 4.30B | 10.95B | 10.46B |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
44.39B | 42.55B | 308.46B | 293.80B | 266.36B | Total Assets |
1.73T | 1.51T | 1.41T | 1.38T | 1.17T | Total Debt |
82.12B | 101.43B | 89.30B | 95.17B | 61.27B | Net Debt |
37.73B | 58.88B | 47.04B | 55.23B | 29.96B | Total Liabilities |
1.61T | 1.38T | 1.31T | 1.27T | 1.05T | Stockholders Equity |
87.07B | 78.99B | 75.51B | 88.07B | 90.65B |
Cash Flow | Free Cash Flow | |||
116.24B | 127.67B | 88.72B | 94.48B | 110.33B | Operating Cash Flow |
125.95B | 134.60B | 95.02B | 98.63B | 114.20B | Investing Cash Flow |
-95.63B | -130.95B | -80.30B | -99.62B | -110.85B | Financing Cash Flow |
-27.91B | 34.99B | -9.76B | 9.06B | -945.65M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
80 Outperform | HK$45.79B | 6.16 | 9.88% | 2.56% | 17.76% | 38.31% | |
64 Neutral | $12.87B | 9.81 | 7.76% | 16985.65% | 12.28% | -7.83% | |
$122.85B | 6.00 | 6.13% | ― | ― | |||
$90.55B | 13.55 | 16.75% | 2.69% | ― | ― | ||
$42.57B | 5.92 | 16.47% | 3.93% | ― | ― | ||
$131.89B | 3.86 | 22.83% | 4.04% | ― | ― | ||
75 Outperform | HK$158.35B | 3.92 | 26.08% | 4.25% | -43.77% | ― |
China Taiping Insurance Holdings Co announced that all resolutions proposed at its Annual General Meeting held on May 30, 2025, were passed by shareholders. This includes the re-election of directors, approval of financial statements, declaration of a final dividend, and re-appointment of KPMG as the independent auditor. The successful passage of these resolutions reflects shareholder confidence and supports the company’s governance and operational continuity.
The most recent analyst rating on (HK:0966) stock is a Hold with a HK$12.00 price target. To see the full list of analyst forecasts on China Taiping Insurance Holdings Co stock, see the HK:0966 Stock Forecast page.
China Taiping Insurance Holdings Co announced its unaudited financial figures and solvency statement for the first quarter of 2025. The announcement highlights the financial performance of its subsidiaries in China, showing a net profit of RMB 299,240,000 and total assets amounting to RMB 128,449,536. The release of these figures is in compliance with regulatory requirements and provides stakeholders with preliminary insights into the company’s financial health and operational efficiency.
China Taiping Insurance Holdings Co. announced the release of its subsidiaries’ solvency report for the first quarter of 2025. The report, which is based on unaudited preliminary financial data, highlights the company’s financial stability and compliance with the China Risk Oriented Solvency System Phase II. This disclosure is expected to reassure shareholders and potential investors about the company’s financial health and regulatory adherence.
China Taiping Insurance Holdings Company Limited has announced the appointment of Mr. ZHOU Lianggang as a non-executive director and a member of the strategy and investment committee, effective March 24, 2025. This strategic appointment is expected to strengthen the company’s leadership and enhance its strategic planning capabilities, potentially impacting its market positioning positively.
China Taiping Insurance Holdings Co has announced the composition of its board of directors, highlighting the roles and functions of each member. The board includes executive, non-executive, and independent non-executive directors, with specific members serving on various committees such as the Audit Committee, Nomination and Remuneration Committee, Risk Management Committee, and Strategy and Investment Committee. This announcement underscores the company’s commitment to strong governance and strategic oversight, which may enhance its operational efficiency and stakeholder confidence.
China Taiping Insurance Holdings Company Limited announced its audited financial results for the year ended December 31, 2024, marking its 95th anniversary and a significant year under the 14th Five-Year Plan. Despite a challenging external environment, the company achieved its strongest financial performance in recent years, with total assets exceeding HK$1.7 trillion and a 36.2% increase in profit attributable to shareholders. The company demonstrated comprehensive improvement in operational quality and efficiency, with significant growth in new business contributions and investment income. Additionally, China Taiping advanced its strategic initiatives in technology finance, green finance, inclusive finance, ageing finance, and digital finance, aligning with national strategies and enhancing its industry positioning.
China Taiping Insurance Holdings Co announced a final ordinary cash dividend of HKD 0.35 per share for the financial year ending December 31, 2024. The ex-dividend date is set for July 9, 2025, with the payment date scheduled for July 22, 2025. This announcement reflects the company’s financial strategy and commitment to delivering shareholder value, potentially reinforcing its market position and investor confidence.
China Taiping Insurance Holdings Company Limited announced the completion of the issuance of undated capital bonds by its subsidiary, Taiping Life Insurance Company Limited, amounting to RMB20 billion. The proceeds will be used to replenish core tier 2 capital, enhancing TPL’s solvency and supporting its sustainable and steady development.
China Taiping Insurance Holdings Co has announced a board meeting scheduled for March 24, 2025, to discuss and approve the company’s annual results for the year ending December 31, 2024, and to consider the payment of a final dividend. This meeting could have implications for the company’s financial performance and shareholder returns, potentially impacting its market position and stakeholder interests.